Insider · CIK 0001927626
Eugene Williams
Files at PMN (ProMIS Neurosciences Inc.). First filing Mar 4, 2026, latest Mar 6, 2026.
In brief
Eugene Williams files SEC Form 4 as director at PMN (ProMIS Neurosciences Inc.). Since Mar 4, 2026, Eugene Williams has reported 2 open-market buys worth $141k and 0 open-market sells worth $0, the latest filed on Mar 6, 2026.
A track record needs three past buys with six months of prices behind them; Eugene Williams has 0, so none is measured yet.
The newest scored trade: bought $49k of PMN on Mar 5, 2026, filed Mar 6, 2026, scored 38 (weak). In the last 12 months: 2 buys worth $141k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PMN: ProMIS Neurosciences Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | ProMIS Neurosciences Inc. | $49k 2,000 shares | +19% | +267% from low-11% from high | |
| 46Moderate | ProMIS Neurosciences Inc. | $92k 4,000 shares | +63% | +237% from low-19% from high |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 20, 2026 | PMN ProMIS Neurosciences Inc. | AGrant or award Option (right to buy)derivative | +5,500 | $0.00 | $0 | 5,500 | May 22, 2026 |
| May 20, 2026 | PMN ProMIS Neurosciences Inc. | AGrant or award Option (right to buy)derivative | +11,000 | $0.00 | $0 | 11,000 | May 22, 2026 |
| Mar 5, 2026 | PMN ProMIS Neurosciences Inc. | POpen-market purchase Common Shares | +2,000 | $24.40 | $49k | 12,397 | Mar 6, 2026 |
| Mar 2, 2026 | PMN ProMIS Neurosciences Inc. | POpen-market purchase Common Shares | +1,000 | $22.53 | $23k | 7,397 | Mar 4, 2026 |
| Mar 3, 2026 | PMN ProMIS Neurosciences Inc. | POpen-market purchase Common Shares | +1,000 | $21.89 | $22k | 8,397 | Mar 4, 2026 |
| Mar 4, 2026 | PMN ProMIS Neurosciences Inc. | POpen-market purchase Common Shares | +2,000 | $24.00 | $48k | 10,397 | Mar 4, 2026 |
| Jun 12, 2025 | PMN ProMIS Neurosciences Inc. | AGrant or award Option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Jun 16, 2025 |
Questions about Eugene Williams
Answered from the filings on this page, as of the latest one.
Is Eugene Williams buying or selling?
In the last 12 months Eugene Williams reported 2 open-market buys worth $141k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $49k of PMN on Mar 5, 2026. Grants, option exercises and tax withholding are not counted.
How did Eugene Williams's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Eugene Williams has 0.
Where does Eugene Williams file Form 4?
Eugene Williams has filed Form 4 at PMN (ProMIS Neurosciences Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.